Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Riding the biotech rollercoaster

Nature volume 418, pages 4–5 (2002)Cite this article

The biotech scene, although volatile, will continue to provide jobs. But potential employees should prepare for a bumpy ride, say Paul Smaglik and Adam Smith.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. editor of Naturejobs,

    Paul Smaglik

  2. editor of Nature Reviews Drug Discovery,

    Adam Smith

Authors
  1. Paul Smaglik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smaglik, P., Smith, A. Riding the biotech rollercoaster. Nature 418, 4–5 (2002). https://doi.org/10.1038/nj6893-04a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nj6893-04a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing